Literature DB >> 19493601

Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure.

Lawrence Yoo1, Daniel Matalon, Robert S Hoffman, David S Goldfarb.   

Abstract

Pregabalin is prescribed for neuropathic pain. We report the first case of pregabalin toxicity in a hemodialysis patient and her successful treatment with hemodialysis. The patient was a 30-year-old woman on long-term hemodialysis therapy who experienced significant myoclonus of the arms and legs when her dose of pregabalin was mistakenly increased. The drug has 3 properties that contribute to making it amenable to removal by hemodialysis: relatively low molecular weight (159.23 Da), relatively low volume of distribution (0.5 L/kg), and not bound to plasma proteins. We achieved hemodialysis clearance of 88.8 mL/min, which was associated with resolution of symptoms immediately after hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19493601     DOI: 10.1053/j.ajkd.2009.04.014

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

Review 1.  Neurologic Complications of Commonly Used Drugs in the Hospital Setting.

Authors:  Elliot T Dawson; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 2.  Have We Just Scratched the Surface? A Narrative Review of Uremic Pruritus in 2020.

Authors:  Claire E Martin; Sergi Clotet-Freixas; Janine F Farragher; Gregory L Hundemer
Journal:  Can J Kidney Health Dis       Date:  2020-10-15

Review 3.  Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease.

Authors:  Flaminia Coluzzi
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

4.  Myoclonus in renal failure: Two cases of gabapentin toxicity.

Authors:  Kenneth R Kaufman; Amay Parikh; Lili Chan; Mary Bridgeman; Milisha Shah
Journal:  Epilepsy Behav Case Rep       Date:  2013-12-29

5.  Two cases of pregabalin neurotoxicity in chronic kidney disease patients.

Authors:  Dong-Won Lee; Hyeon Jeong Lee; Hyun-Jung Kim; Se-Ho Chang; Dong Jun Park
Journal:  NDT Plus       Date:  2011-04

6.  Can we not work together to help family practitioners become more effective pain managers?

Authors:  Jeffrey Fudin; Timothy J Atkinson; Mena Raouf; Michael E Schatman
Journal:  J Pain Res       Date:  2016-10-13       Impact factor: 3.133

7.  Rational dosing of gabapentin and pregabalin in chronic kidney disease.

Authors:  Mena Raouf; Timothy J Atkinson; Meredith W Crumb; Jeffrey Fudin
Journal:  J Pain Res       Date:  2017-01-27       Impact factor: 3.133

Review 8.  Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches.

Authors:  Zoe M Lipman; Vijayakumar Paramasivam; Gil Yosipovitch; Michael J Germain
Journal:  Clin Kidney J       Date:  2021-10-14

9.  Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure.

Authors:  F Courtois; D Borrey; V Haufroid; P Hantson
Journal:  Indian J Nephrol       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.